Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by DonRudyon Dec 31, 2020 5:41pm
219 Views
Post# 32205898

RE:RE:RE:RE:RE:RE:Nextleaf profitable moving into 2021.

RE:RE:RE:RE:RE:RE:Nextleaf profitable moving into 2021.

Nextleaf is a different extraction process than labs and valens which is why they're profitable in today's market. 

Being a step later in the game than labs and valens is an advantage as a company can learn from their mistakes. Structuring their contracts to split the final product is what will cause write downs to not take place. 


The 100kg of CBD oils is a contract for cash. Not a split like the other contracts. This is the sale in the link I provided which made them profitable. Within that contract once the 100kg was shipped another 100kg would be on the table moving forward. 

being in the black as a company is sure better than in the red, no matter how you spin it. 

<< Previous
Bullboard Posts
Next >>